Focus: Avantor is a $7B global provider of critical materials, equipment, and services for pharmaceutical, biotech, and life science research. The company operates as a large-scale supply chain and manufacturing partner to the biopharma industry.
Profile data last refreshed 19h ago · AI intelligence enriched 2mo ago
Hot — 474 jobs added in 30d
Net +184 (474 new, 290 removed). Aggressive expansion phase.
Avantor suits professionals seeking stable supply-chain, manufacturing, or R&D support roles within pharma infrastructure, but not those targeting clinical development or branded drug commercialization.
Help build intelligence for Avantor
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Avantor's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles